Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.

GMP Radiopharmaceuticals Radiopharmacy cGRPP

Journal

EJNMMI radiopharmacy and chemistry
ISSN: 2365-421X
Titre abrégé: EJNMMI Radiopharm Chem
Pays: England
ID NLM: 101714628

Informations de publication

Date de publication:
12 Feb 2021
Historique:
received: 25 11 2020
accepted: 22 01 2021
entrez: 13 2 2021
pubmed: 14 2 2021
medline: 14 2 2021
Statut: epublish

Résumé

This guideline on current good radiopharmacy practice (cGRPP) for small-scale preparation of radiopharmaceuticals represents the view of the Radiopharmacy Committee of the European Association of Nuclear Medicine (EANM). The guideline is laid out in the format of the EU Good Manufacturing Practice (GMP) guidelines as defined in EudraLex volume 4. It is intended for non-commercial sites such as hospital radiopharmacies, nuclear medicine departments, research PET centres and in general any healthcare establishments. In the first section, general aspects which are applicable to all levels of operations are discussed. The second section discusses the preparation of small-scale radiopharmaceuticals (SSRP) using licensed generators and kits. Finally, the third section goes into the more complex preparation of SSRP from non-licensed starting materials, often requiring a purification step and sterile filtration. The intention is that the guideline will assist radiopharmacies in the preparation of diagnostic and therapeutic SSRP's safe for human administration.

Identifiants

pubmed: 33580358
doi: 10.1186/s41181-021-00123-2
pii: 10.1186/s41181-021-00123-2
pmc: PMC7881071
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8

Références

EJNMMI Radiopharm Chem. 2020 Feb 12;5(1):7
pubmed: 32052212
Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):842-8
pubmed: 20198473
Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):835-41
pubmed: 20198474
J Labelled Comp Radiopharm. 2014 Aug;57(10):615-20
pubmed: 25196257
Med Etika Bioet. 2002 Spring-Summer;9(1-2):12-9
pubmed: 16276663
EJNMMI Radiopharm Chem. 2017;2(1):8
pubmed: 29503849
Eur J Nucl Med Mol Imaging. 2010 May;37(5):1049-62
pubmed: 20306035

Auteurs

Nic Gillings (N)

Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark. ngil0001@regionh.dk.

Olaug Hjelstuen (O)

GE Healthcare, Pharmaceutical Diagnostics, Oslo, Norway.

Jim Ballinger (J)

King's College London, Division of Imaging Sciences and Biomedical Engineering, London, UK.

Martin Behe (M)

Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland.

Clemens Decristoforo (C)

Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.

Philip Elsinga (P)

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.

Valentina Ferrari (V)

MSD Animal Health, Milton Keynes, UK.

Petra Kolenc Peitl (PK)

University Medical Centre Ljubljana, Ljubljana, Slovenia.

Jacek Koziorowski (J)

Independant Consultant, Norrköping, Sweden.

Peter Laverman (P)

Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.

Thomas L Mindt (TL)

Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria.

Oliver Neels (O)

Institute for Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

Meltem Ocak (M)

Department of Pharmaceutical Technology, Istanbul University, Istanbul, Turkey.

Marianne Patt (M)

Department for Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.

Sergio Todde (S)

Tecnomed Foundation, University of Milano - Bicocca, Milan, Italy.

Classifications MeSH